254. ポルフィリン症 Porphyria Clinical trials / Disease details

臨床試験数 : 70 / 薬物数 : 54 - (DrugBank : 19) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04923516 (ClinicalTrials.gov)	June 2021	8/6/2021	Prevalence of Acute Hepatic Porphyria	Prevalence of Acute Hepatic Porphyria in Population With Suggestive Clinical Picture	Acute Hepatic Porphyria	Other: Dosage of Delta-aminolevulinic acid and Porphobilinogen	Association pour la Recherche en Medecine Interne	NULL	Not yet recruiting	18 Years	60 Years	All	500		NULL
2	NCT01550705 (ClinicalTrials.gov)	March 2012	5/3/2012	Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria	Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria	Erythropoietic Protoporphyria (EPP);X Linked Erythropoietic Protoporphyria	Drug: Isoniazid	University of Utah	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Icahn School of Medicine at Mount Sinai;University of Alabama at Birmingham;University of California, San Francisco;University of Texas	Terminated	18 Years	N/A	All	11	N/A	United States